TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients - Related Studies

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

This study is currently recruiting participants.

Study NCT00133887. Last updated on June 20, 2008. Information provided by Hospices Civils de Lyon

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Skin Cancer
		Kidney Transplantation

2	Additional conditions recognized in this trial
		Skin Neoplasms

3	More general conditions related to this trial
		Neoplasms
		Neoplasms by Site
		Skin Diseases

4	Interventions listed in this trial
		rapamycin
		ciclosporine
		tacrolimus

5	Additional drug interventions recognized in this trial
		Sirolimus

6	More general drug interventions related to this trial
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antibiotics, Antineoplastic
		Antifungal Agents
		Antineoplastic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Hospices Civils de Lyon